John T. Blake
Senior Vice President, Finance at aTyr Pharma, Inc.
This person is connected to 154 people.
Senior Director-Business Development at Volcano Corp.
Chairman, President & Chief Executive Officer at Verb Surgical, Inc.
Chief Financial Officer at Acutus Medical, Inc.
Partner at CloudBreak Capital LLC
President & Chief Executive Officer at MRI Interventions, Inc.
Vice President & General Manager, US Commercial Sales & Operations at Opsens, Inc.
Chief Executive Officer & Director at Metronom Health, Inc.
Former President & Managing Director, Volcano Japan at Volcano Corp.
President, Commercial & Manufacturing Operations at Elixir Medical Corp.
Senior Director, Investor Relations at aTyr Pharma, Inc.
August 28, 2017
Paths to John T. Blake
Connections via Relationship Science
John T. Blake
Since 1971, National University has been dedicated to making lifelong learning opportunities accessible, challenging, and relevant to a diverse student population. As a nonprofit institution, National University invests in its students by providing them with quality educational instruction and learning technologies, superior faculty, and exemplary student services.
Senior Vice President, Finance
2015 - Current
aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of innovative therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler in 2005 and is headquartered in San Diego, CA.
Director-Financial Planning & Analysis
2007 - 2015
Volcano Corporation develops, manufactures and commercializes a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies.
The Company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab and single use disposable imaging catheters unique to our system. Our IVUS offerings are used by clinicians to measure the stage and severity of disease present in cardiac and peripheral vessels. IVUS is also used in post-stent placement procedures to confirm adequate expansion of the stent and full apposition to the vessel wall. Volcano IVUS offers unique features, including both phased array and rotational IVUS imaging catheters and advanced functionality options, such as VH® IVUS tissue characterization, ChromaFlo® and FFR (fractional flow reserve) technology.
Volcano also provides functional management (FM) consoles and single-use pressure and flow guide wires, which are used to gauge the impact of arterial plaque on blood flow and pressure. The Company is also developing a line of ultra-high resolution Optical Coherence Tomography (OCT) systems and catheters, Forward Looking IVUS (FLIVUS) catheters and other image-guided therapy products. Currently, more than 3,900 Volcano s5/s5i IVUS and FM systems are installed worldwide, with approximately half of its revenues coming from outside the United States
aTyr Pharma, Inc. raised money in a private placement transaction
You've reached your 7 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!